StockData
Veradermics, Inc logo

Veradermics, Inc (MANE) stock

MANENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$124.86−0.78 (-0.62%)

Close on Nov 18, 2026Market cap $5.22BP/E –Yield –

Veradermics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$71.63M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$71.63M–
FY2024Dec 31, 2024-$23.69M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$14.51M–
Q1 FY2026Mar 31, 2026-$21.17M–
Q2 FY2025Jun 30, 2025-$15.64M–
Q1 FY2025Mar 31, 2025-$13.34M–

More Veradermics figures

See a number that looks wrong?